No Picture
Trading Ideas

How Do You Trade Volatility? What You Need to Know

How do you trade volatility? More and more people want to know the answer to this question. The stock market is a volatile place. It has big drops such as the dotcom bubble, housing market crisis and, most recently, the coronavirus. And that scares a lot of investors. But it shouldn’t worry you. Here we’ll go over some ways you can trade volatility.
But first…
What is Volatility?

Price volatility is the change in a security or market’s price over a given time period. The more a price or index moves, the higher the volatility. And the higher the volatility, the higher the …read more […]

No Picture
Trading Ideas

Berkshire operating results fall even as Apple boosts profit

Berkshire said operating profit fell 32% to $5.48 billion from $8.07 billion a year earlier. Net income rose 82% to $30.14 billion, or $18,994 per Class A share, from $16.52 billion, or $10,119 per share, a year earlier. Berkshire’s share price is lagging the Standard & Poor’s 500 for a second straight year despite outperforming from July to September. …read more […]

No Picture
Trading Ideas

Berkshire Buys Back Another $9 Billion of Stock in Record Year

(Bloomberg) — Warren Buffett is keeping up his record pace of buybacks.Berkshire Hathaway Inc. spent the third quarter buying back $9 billion of its own stock, after Buffett abandoned his long-held aversion to that use of capital. That total was more than the conglomerate has repurchased in any full year.Key InsightsBuffett was able to chip away at Berkshire’s cash pile in the third quarter, with that war chest dropping slightly to $145.7 billion. The funds, which still give him plenty of capital to deploy into acquisitions, stock purchases or buybacks, have recently been accumulating faster than Buffett can put it …read more […]

No Picture
Trading Ideas

Combative U.S. FDA panel votes against Biogen Alzheimer's drug

The FDA still could decide to approve the drug, aducanumab, making it the first new Alzheimer’s treatment in decades. Several of the 11 panel members expressed resentment that the FDA’s early view of aducanumab – which was made public on Wednesday – was biased toward a favorable outcome for Biogen. …read more […]

No Picture
Trading Ideas

Biden Win With Undecided Senate Flips European Market’s Outlook

(Bloomberg) — With Joe Biden on a path to winning the U.S. presidency but control of the Senate still up in the air, investors in European stocks have been forced to review their outlook for some key industries.Market players had spent months positioning for post-election outperformance in European renewable-energy and cyclical stocks, accompanied by weakness in health care and technology. The thinking was that a “blue wave” of Democratic wins would lead to increased fiscal stimulus and support for alternative power, along with higher corporate taxes and possibly legislation that hurt drug companies.Now, Biden looks to be just squeaking out …read more […]